On July 9, 2024, Aspira Women's Health Inc. closed the transaction. The company issued an aggregate of 1,248,529 shares of its common stock and accompanying warrants to purchase an equal number of shares of common stock at a price of $1.53 per share and accompanying warrant for the gross proceeds of $1,910,249. The transaction included participation from from certain existing shareholders and company insiders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.61 USD | +26.77% |
|
+45.05% | -60.54% |
Jul. 09 | Aspira Women's Health Inc. announced that it has received $1.910249 million in funding | CI |
Jul. 02 | Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Ahead of Powell Speech | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.54% | 15.81M | |
-37.33% | 8.27B | |
+14.86% | 3.67B | |
+7.38% | 2.36B | |
-25.96% | 1.87B | |
-17.30% | 1.73B | |
+36.49% | 1.14B | |
+32.58% | 823M | |
-7.64% | 678M | |
-18.37% | 573M |
- Stock Market
- Equities
- AWH Stock
- News Aspira Women's Health Inc.
- Aspira Women's Health Inc. announced that it has received $1.910249 million in funding